Regulation & Compliance

As AI assistants accelerate code generation, Moderne's new tooling offers enterprises a way to automate large-scale Python fixes and control code sprawl.

A new study reveals Apache Iceberg is core to enterprise AI, but its rapid adoption has created a critical 'operational gap' that companies are now rushing to fill.

A new program helps personal injury lawyers offer holistic support, guiding clients through the complex world of disability rights after an accident.

The Swedish tech firm will debut its AI Checklist Builder and Safety Alerts at CONEXPO 2026, aiming to transform high-risk industrial operations.

The virtual care provider extends its specialized behavioral health services for Medicare patients to Arizona, Illinois, and Indiana amid a provider shortage.

Innoviva prepares for a key investor conference, spotlighting its shift to specialty drugs and navigating questions on its diversified growth strategy.

Clene Inc. faces investors with promising data for ALS and MS, but a looming cash crunch makes its upcoming conference a critical test of survival.

An international team receives a major grant to use artificial intelligence to predict survival and treatment response, offering new hope for a deadly disease.

FinTech leader Derivative Path promotes Zack Nagelberg to President, signaling a strategic push into AI-driven risk management for evolving capital markets.

The cannabis giant's landmark debt deal signals new institutional confidence, but a high interest rate reveals the industry's costly reality.

Reunion Neuroscience hits the investor conference circuit, seeking capital to advance its groundbreaking psychedelic-inspired therapies for depression and anxiety.

Fractal's new healthcare AI has surpassed leading models from OpenAI and Google, signaling a major leap for India's sovereign AI ambitions and public health.

The mobile health firm now reaches 25 states with its tech-driven model, aiming to close care gaps and answer federal critics of in-home assessments.

A new partnership between WELL Health and HEALWELL AI uses artificial intelligence to find trial participants, but puts patient consent at the forefront.

As Signet prepares its Q4 earnings, all eyes are on whether its brand power can overcome cautious consumer spending and set the tone for the luxury market.

An advocacy group challenges the University of Denver's animal-law program, demanding proof of impact and raising questions about donor funds.

With BRINSUPRI revenues set to hit $1B, Insmed is pouring cash into a high-stakes pipeline. Can it outrun its massive burn rate to deliver the next breakthrough?

The insurer's full-year income soared 56% on strategic shifts, but declining premiums and a weaker Q4 highlight the challenges of its long-term plan.

Early data on YOLT-202 shows it can safely restore normal protein levels in patients with Alpha-1 Antitrypsin Deficiency, a major step toward a cure.

Serina Therapeutics enrolls the first patient in a trial for SER-252, a novel Parkinson's therapy designed to improve symptoms without current side effects.